drugset / Trial / NCT00454688
Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of different doses of asimadoline in the treatment of patients with irritable bowel syndrome.
Timeline
- Start
- 2006-08
- Primary completion
- 2007-11
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asimadoline | Small molecule | 0.15 mg | Oral |
| Subject | Asimadoline | Small molecule | 0.5 mg | Oral |
| Subject | Asimadoline | Small molecule | 1 mg | Oral |